Share This

Hot News

【新冠肺炎】預防感染病毒輝瑞啟動首款口服藥中後期試驗0.0上報 @ 2021-09-28T20: Back Hot News
Keyword:導航 不能 手機 能用 歲生日 停止支援
Concept:
新型病毒引發的肺炎(COVID-19)持續擴散,截至28日14時,全球確診病例為2億3312萬2775例,累計死亡人數達4...
透過口服藥,加強免疫力,阻絕新冠病毒侵害。就算被感染,也不用怕傳給同住家人?新冠病毒候選口服藥物有沒有效果,未來幾個月,我們就會有答案。哪些藥廠是主要角逐 ...
治療新冠病毒的口服藥有望最早在年內問世。美國兩家藥企默克(Merck)和輝瑞(Pfizer)正在包括日本在內的各國推進能用於輕症者的藥劑……
財經頻道/綜合報導〕美商默沙東(MSD)、輝瑞(Pfizer)及部分日本藥廠都已開發武肺口服藥劑,並邁入最終臨床試驗階段。日媒報導,美國衛生與社會福利部(HHS)已與 ...
雖然新冠肺炎疫苗降低了新冠肺炎疫情所造成的重症與致死率,但隨著各國都正准備新冠病毒(SARS-CoV-2)長期共存,輝瑞...

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.